References
1. World Health Organization. Rolling updates on coronavirus disease
(COVID-19) 2020 [Available from:
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
2. Johns Hopkins University. COVID-19 Dashboard by the Center for
Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)
2020 [Available from: https://coronavirus.jhu.edu/map.html.
3. Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL,
et al. The prevalence of symptoms in 24,410 adults infected by the novel
coronavirus (SARS-CoV-2; COVID-19): A systematic review and
meta-analysis of 148 studies from 9 countries. PLoS One.
2020;15(6):e0234765.
4. García LF. Immune Response, Inflammation, and the Clinical Spectrum
of COVID-19. Frontiers in Immunology. 2020;11(1441).
5. Mahmoodpoor A, Nader ND. Immune Responses to the Novel Coronavirus-2:
Friend or Foe? Immunological Investigations. 2020:1-3.
6. Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus
infections and immune responses. Journal of Medical Virology.
2020;92(4):424-32.
7. Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. Characterization of
spike glycoprotein of SARS-CoV-2 on virus entry and its immune
cross-reactivity with SARS-CoV. Nature Communications. 2020;11(1):1620.
8. Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, et al.
Characterization of the receptor-binding domain (RBD) of 2019 novel
coronavirus: implication for development of RBD protein as a viral
attachment inhibitor and vaccine. Cellular & Molecular Immunology.
2020;17(6):613-20.
9. Altmann DM, Boyton RJ. SARS-CoV-2 T cell immunity: Specificity,
function, durability, and role in protection. Science Immunology.
2020;5(49):eabd6160.
10. Chu H, Chan JF-W, Wang Y, Yuen TT-T, Chai Y, Hou Y, et al.
Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and
SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the
Pathogenesis of COVID-19. Clinical Infectious Diseases. 2020.
11. Blanco-Melo D, Nilsson-Payant BE, Liu W-C, Uhl S, Hoagland D, Møller
R, et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of
COVID-19. Cell. 2020;181(5):1036-45.e9.
12. Guillon A, Hiemstra PS, Si-Tahar M. Pulmonary immune responses
against SARS-CoV-2 infection: harmful or not? Intensive Care Med.
2020:1-4.
13. Lingeswaran M, Goyal T, Ghosh R, Suri S, Mitra P, Misra S, et al.
Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative
Review. Indian J Clin Biochem. 2020;35(3):260-73.
14. Shurin MR, Morris A, Wells A, Wheeler SE. Assessing Immune Response
to SARS-CoV-2 Infection. Immunotargets Ther. 2020;9:111-4.
15. Lin Q, Zhu L, Ni Z, Meng H, You L. Duration of serum neutralizing
antibodies for SARS-CoV-2: Lessons from SARS-CoV infection. J Microbiol
Immunol Infect. 2020:S1684-182(20)30075-X.
16. Oberemok VV, Laikova KV, Yurchenko KA, Marochkin NA, Fomochkina II,
Kubyshkin AV. SARS-CoV-2 will constantly sweep its tracks: a vaccine
containing CpG motifs in ’lasso’ for the multi-faced virus. Inflamm Res.
2020:1-12.
17. Ng OW, Chia A, Tan AT, Jadi RS, Leong HN, Bertoletti A, et al.
Memory T cell responses targeting the SARS coronavirus persist up to 11
years post-infection. Vaccine. 2016;34(17):2008-14.
18. Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, et al. Profiling
Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19).
Clinical Infectious Diseases. 2020.
19. Theel ES, Slev P, Wheeler S, Couturier MR, Wong SJ, Kadkhoda K. The
Role of Antibody Testing for SARS-CoV-2: Is There One? Journal of
Clinical Microbiology. 2020;58(8):e00797-20.
20. Ni L, Ye F, Cheng M-L, Feng Y, Deng Y-Q, Zhao H, et al. Detection of
SARS-CoV-2-specific humoral and cellular immunity in COVID-19
convalescent individuals. Immunity. 2020.
21. Le Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, et al.
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and
uninfected controls. Nature. 2020.
22. Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, et al. Immune cell
profiling of COVID-19 patients in the recovery stageby single-cell
sequencing. Cell Discovery. 2020;6(1):31.
23. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of
Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan,
China. Clinical Infectious Diseases. 2020.
24. Kumar S, Nyodu R, Maurya VK, Saxena SK. Host Immune Response and
Immunobiology of Human SARS-CoV-2 Infection. Coronavirus Disease 2019
(COVID-19). 2020:43-53.
25. Yuan J, Kou S, Liang Y, Zeng J, Pan Y, Liu L. PCR Assays Turned
Positive in 25 Discharged COVID-19 Patients. Clinical infectious
diseases : an official publication of the Infectious Diseases Society of
America. 2020.
26. Wong J, Koh WC, Momin RN, Alikhan MF, Fadillah N, Naing L. Probable
causes and risk factors for positive SARS-CoV-2 test in recovered
patients: Evidence from Brunei Darussalam. Journal of medical virology.
2020.
27. Qiao XM, Xu XF, Zi H, Liu GX, Li BH, Du X, et al. Re-positive Cases
of Nucleic Acid Tests in Discharged Patients With COVID-19: A Follow-Up
Study. Frontiers in Medicine. 2020;7.
28. Wise J. Covid-19: New coronavirus variant is identified in UK. BMJ.
2020;371:m4857.
29. Liang C, Cao J, Liu Z, Ge F, Cang J, Miao C, et al. Positive RT-PCR
test results after consecutively negative results in patients with
COVID-19. Infectious diseases (London, England). 2020;52(7):517-9.
30. Kang YJ. South Korea’s COVID-19 Infection Status: from the
Perspective of Re-Positive after Viral Clearance by Negative Testing.
Disaster medicine and public health preparedness. 2020:1-7.
31. Zhu H, Fu L, Jin Y, Shao J, Zhang S, Zheng N, et al. Clinical
features of COVID-19 convalescent patients with re-positive nucleic acid
detection. Journal of clinical laboratory analysis. 2020;34(7):e23392.
32. Wang X, Xu H, Jiang H, Wang L, Lu C, Wei X, et al. The Clinical
Features and Outcomes of Discharged Coronavirus Disease 2019 Patients:A
Prospective Cohort Study. QJM : monthly journal of the Association of
Physicians. 2020.
33. Liu C, Ye L, Xia R, Zheng X, Yuan C, Wang Z, et al. Chest CT and
Clinical Follow-up of Discharged Patients with COVID-19 in Wenzhou City,
Zhejiang, China. Annals of the American Thoracic Society. 2020.
34. Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et
al. Virological assessment of hospitalized patients with COVID-2019.
Nature. 2020;581(7809):465-9.
35. World Health Organization. Diagnostic testing for SARS-CoV-2 2020
[Available from:
https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2.
36. Alcoba-Florez J, Gil-Campesino H, Artola DG-Md, González-Montelongo
R, Valenzuela-Fernández A, Ciuffreda L, et al. Sensitivity of different
RT-qPCR solutions for SARS-CoV-2 detection. International Journal of
Infectious Diseases. 2020;99:190-2.
37. Li Y, Hu Y, Yu Y, Zhang X, Li B, Wu J, et al. Positive result of
Sars-Cov-2 in faeces and sputum from discharged patient with COVID-19 in
Yiwu, China. Journal of medical virology. 2020.
38. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A
familial cluster of pneumonia associated with the 2019 novel coronavirus
indicating person-to-person transmission: a study of a family cluster.
Lancet. 2020;395(10223):514-23.
39. Surkova E, Nikolayevskyy V, Drobniewski F. False-positive COVID-19
results: hidden problems and costs. Lancet Respir Med.
2020:S2213-600(20)30453-7.
40. Chen WJ, Yang JY, Lin JH, Fann CS, Osyetrov V, King CC, et al.
Nasopharyngeal shedding of severe acute respiratory syndrome-associated
coronavirus is associated with genetic polymorphisms. Clinical
infectious diseases : an official publication of the Infectious Diseases
Society of America. 2006;42(11):1561-9.
41. Ye G, Pan Z, Pan Y, Deng Q, Chen L, Li J, et al. Clinical
characteristics of severe acute respiratory syndrome coronavirus 2
reactivation. J Infect. 2020;80(5):e14-e7.
42. Liu T, Wu S, Zeng G, Zhou F, Li Y, Guo F, et al. Recurrent positive
SARS-CoV-2: Immune certificate may not be valid. Journal of medical
virology. 2020.
43. Yao X-H, He Z-C, Li T-Y, Zhang H-R, Wang Y, Mou H, et al.
Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a
ready-for-discharge patient. Cell Research. 2020;30(6):541-3.
44. Yuan B, Liu HQ, Yang ZR, Chen YX, Liu ZY, Zhang K, et al. Recurrence
of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during
medical isolation observation. Scientific reports. 2020;10(1):11887.
45. Tillett RL, Sevinsky JR, Hartley PD, Kerwin H, Crawford N, Gorzalski
A, et al. Genomic evidence for reinfection with SARS-CoV-2: a case
study. The Lancet Infectious Diseases. 2020.
46. Wang P. Recurrent presence of SARS-CoV-2 RNA in a 33-year-old man.
Journal of medical virology. 2020.
47. Lafaie L, Célarier T, Goethals L, Pozzetto B, Sylvain G, Ojardias E,
et al. Recurrence or Relapse of COVID-19 in Older Patients: A
Description of Three Cases. Journal of the American Geriatrics Society.
2020.
48. Batisse D, Benech N, Botelho-Nevers E, Bouiller K, Collarino R,
Conrad A, et al. Clinical recurrences of COVID-19 symptoms after
recovery: viral relapse, reinfection or inflammatory rebound? The
Journal of infection. 2020.
49. Zhuang SF, Hu J, Qiao N, Lan ZH, Lai JY, Wu JG, et al. Low-grade
fever during COVID-19 convalescence: A report of 3 cases. World journal
of clinical cases. 2020;8(12):2655-61.
50. Liu F, Cai ZB, Huang JS, Yu WY, Niu HY, Zhang Y, et al. Positive
SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19:
dynamic results from 108 days of follow-up. Pathogens and disease.
2020;78(4).
51. Li XJ, Zhang ZW, Zong ZY. A case of a readmitted patient who
recovered from COVID-19 in Chengdu, China. Crit Care. 2020;24(1).
52. Peng J, Wang M, Zhang G, Lu E. Seven discharged patients turning
positive again for SARS-CoV-2 on quantitative RT-PCR. Am J Infect
Control. 2020.
53. Loconsole D, Passerini F, Palmieri VO, Centrone F, Sallustio A,
Pugliese S, et al. Recurrence of COVID-19 after recovery: a case report
from Italy. Infection. 2020:1-3.
54. Zhou X, Zhou J, Zhao J. Recurrent pneumonia in a patient with new
coronavirus infection after discharge from hospital for insufficient
antibody production: A case report. BMC Infect Dis. 2020;20(1).
55. Duggan NM, Ludy SM, Shannon BC, Reisner AT, Wilcox SR. A case report
of possible novel coronavirus 2019 reinfection. The American journal of
emergency medicine. 2020.
56. Helleberg M, Niemann CU, Moestrup K, Kirk O, Lebech AM, Lane C, et
al. Persistent COVID-19 in an Immunocompromised Patient Temporarily
Responsive to Two Courses of Remdesivir Therapy. The Journal of
infectious diseases. 2020.
57. Bongiovanni M, Basile F. Re-infection by COVID-19: a real threat for
the future management of pandemia? Infectious diseases (London,
England). 2020;52(8):581-2.
58. Cai S, Sun W, Li M, Dong L. A complex COVID-19 case with rheumatoid
arthritis treated with tocilizumab. Clin Rheumatol. 2020.
59. Gomez-Mayordomo V, Montero-Escribano P, Matías-Guiu JA,
González-García N, Porta-Etessam J, Matías-Guiu J. Clinical exacerbation
of SARS-CoV2 infection after fingolimod withdrawal. Journal of medical
virology. 2020.